Երկիր: Բելգիա
Լեզու: անգլերեն
Աղբյուրը: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
Bordetella Pertussis Filamentous Hemagglutinin (FHA) 8 µg/dose; Diphtheria Toxoid (DT) >= 2 IU/dose; Poliovirus Type 3 (inactivated) 32 D-antigen U/1 dose; Pertactin (Bordetella Pertussis Antigen) 2,5 µg/dose; Bordetella Pertussis Toxoid (PT) 8 µg/dose; Tetanus Toxoid >= 20 IU/dose; Poliovirus Type 2 (inactivated) 8 D-antigen U/1 dose; Poliovirus Type 1 (inactivated) 40 D-antigen U/1 dose
GlaxoSmithKline Biologicals SA-NV
J07CA02
Diphteria Toxoid, Adsorbed; Poliomyelitis Virus, Inactivated; Tetanus Toxoid Adsorbed; Bordetella Pertussis Antigen, Proteins
Suspension for injection in pre-filled syringe
Diphteria Toxoid, Adsorbed; Poliomyelitis Virus, Inactivated; Tetanus Toxoid Adsorbed; Bordetella Pertussis Antigen, Proteins
Intramuscular use
Diphtheria-Pertussis-Poliomyelitis-Tetanus
CTI code: 270435-02 - Pack size: 10 x 1 dose (0.5 (0.5) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 270435-01 - Pack size: 1 dose (0.5 (0.5) - Commercialisation status: YES - FMD code: 05400571000464 - CNK code: 2374429 - Delivery mode: Medical prescription
Commercialised: Yes
2005-01-31